文献速递临床试验与 GCP真实世界研究与卫生经济

远程医疗护理对心力衰竭的健康有效性和成本效果:一项随机对照试验的研究方案

Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2016-12-12

本研究为丹麦TeleCare North心力衰竭试验,采用多中心、两臂、平行组、非盲、优效性随机对照设计,比较远程医疗(Telekit)方案与常规护理对心力衰竭患者的健康有效性和成本效果。计划招募600名符合国家指南诊断且NYHA心功能2、3或4级的患者,主要结局为健康相关生活质量变化和增量成本效果比。

要点

  • 多中心、两臂、平行组、非盲、优效性随机对照试验,计划招募600名心衰患者。
  • 纳入标准为按国家指南诊断且NYHA心功能2、3或4级,并有永久居留权且有意愿使用远程医疗。
  • 主要结局为健康相关生活质量变化和增量成本效果比,次要结局包括死亡率和生理指标变化。

核心结论

  • TeleCare North心力衰竭试验旨在改善远程医疗护理对心力衰竭患者健康有效性和成本效果的国际证据基础。
  • 预期试验结果可推广至丹麦所有市镇,并为进一步的国际研究提供启发。

研究设计与样本

  • 研究为多中心、两臂、平行组、非盲、优效性随机对照试验,在丹麦北丹麦地区地理范围内由门诊医疗中心负责招募符合条件的参与者。
  • 计划招募600名参与者,纳入标准为按国家指南诊断且NYHA心功能2、3或4级,并有永久居留权且有意愿使用远程医疗护理。

主要发现

  • 研究比较远程医疗(Telekit)方案与常规护理对心力衰竭患者的健康有效性和成本效果。
  • 主要结局为从基线至随访的健康相关生活质量变化(采用堪萨斯城心肌病问卷、EuroQol EQ-5D-5L问卷和简短健康调查[SF-36]评估)和增量成本效果比。
  • 次要结局为死亡率和生理指标(如血压、脉搏和体重)的变化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several heart failure studies have shown promising results for implementing telehealthcare. These studies have led to clinical and political interest in telehealthcare as a way to improve heart failure outcomes and lower costs. However, there is a need for large-scale clinical trials with cost-effectiveness assessments. METHODS/DESIGN: The present study is known as the TeleCare North Heart Failure Trial in Denmark. We are studying the health effectiveness and cost-effectiveness of a telehealth (Telekit) solution compared with usual care for patients with heart failure. The design is a multicenter, two-arm, parallel-group, nonblinded, superiority randomized controlled trial. Outpatient healthcare centers will be responsible for recruiting eligible participants (600 participants are expected) for the trial in the geographic area of the North Denmark Region. Participants are qualified for inclusion if they have been diagnosed according to national guidelines and are categorized in New York Heart Association class 2, 3, or 4. Patients must have a permanent residence and be motivated to use telehealth care. The primary outcomes are changes in health-related quality of life (assessed using the Kansas City Cardiomyopathy Questionnaire, the EuroQol EQ-5D-5L questionnaire, and the Short Form Health Survey [SF-36]) and in the incremental cost-effectiveness ratio measured from baseline to follow-up. The secondary outcomes are changes in mortality and in physiological indicators such as blood pressure, pulse, and weight. DISCUSSION: The TeleCare North Heart Failure Trial is intended to improve the international evidence base for the health effectiveness and cost-effectiveness of telehealthcare for patients with heart failure. The expectation is that the results of the trial can be generalized to all municipalities in Denmark and serve as an inspiration for further international research. TRIAL REGISTRATION: ClinicalTrials.gov ( NCT02860013 ). Registered on 28 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cichosz SL, Ehlers LH, Hejlesen O, et al. Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial. Trials. 2016. PMID: 27955682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。